Executive Director
Eli Lilly and Company
Indianapolis, Indiana, United States
Nieves Velez de Mendizabal re-joined Eli Lilly & Co. in 2024 as Head of Pharmacometrics, bringing more than 15 years of experience in academia, consulting, and the pharmaceutical industry. I hold a BS and MS in Computer Engineering and Science, and a Ph.D. in Computer Science from the University of the Basque Country (Spain). During my Ph.D., she interned at Harvard Medical School.
Nieves has worked in quantitative analysis fields such as systems biology, pharmacometrics, bioinformatics, graph theory, and data mining. Her post-doctoral research was conducted at the University of Navarra and Indiana University, where she was later promoted to Assistant Professor. In 2014, Nieves joined Eli Lilly's PK/PD & Pharmacometrics Department as pharmacometrician, and in 2020, she transitioned to Metrum Research Group. In 2022, She joined Gilead Sciences Inc to build the Pharmacometrics group. She has maintained an adjunct position at Indiana University since 2014 and is involved with La Casa de España in Indiana. She has dedicated to promoting and advancing the Pharmacometrics discipline and have consistently contributed to external conferences. She excels at creating unity, developing bonds, and mentoring early-career scientists. She believes in the importance of diversity and innovative approaches in scientific research.
Disclosure information not submitted.
Saturday, October 18, 2025
11:15 AM - 11:45 AM MDT